|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/30 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2976360 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14714586.6 |
| Date of filing the European patent application | 2014-03-17 | |
| (97) | Date of publication of the European application | 2016-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/000719 |
| Date | 2014-03-17 |
| (87) | Number | WO 2014/146778 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| PCT/EP2013/0008 | 2013-03-18 | WO |
| (72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
|
| (73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP |
| (54) | THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |
| THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |